BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 37541330)

  • 1. Programming of Vascular Dysfunction in the Intrauterine Milieu of Diabetic Pregnancies.
    Sallam NA; Palmgren VAC; Singh RD; John CM; Thompson JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy.
    Tropea T; Mavichak W; Evangelinos A; Brennan-Richardson C; Cottrell EC; Myers JE; Johnstone ED; Brownbill P
    J Hypertens; 2023 Nov; 41(11):1675-1687. PubMed ID: 37694528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity.
    Guglielmini G; Falcinelli E; Piselli E; Mezzasoma AM; Tondi F; Alfonsi L; De Luca C; Fino V; Favilli A; Parrettini S; Minuz P; Torlone E; Gresele P; Gerli S
    Am J Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38582292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus.
    Hocher CF; Chen X; Zuo J; Horvathova K; Hocher B; Krämer BK; Chu C
    Diabetes Metab Res Rev; 2023 Nov; 39(8):e3704. PubMed ID: 37553983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When nitrosative stress hits the endoplasmic reticulum: Possible implications in oxLDL/oxysterols-induced endothelial dysfunction.
    Nasoni MG; Crinelli R; Iuliano L; Luchetti F
    Free Radic Biol Med; 2023 Nov; 208():178-185. PubMed ID: 37544487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial on the Special Issue Titled "Pathology and Diagnosis of Gynecologic Diseases".
    Giacometti C; Ludwig K
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurturing through Nutrition: Exploring the Role of Antioxidants in Maternal Diet during Pregnancy to Mitigate Developmental Programming of Chronic Diseases.
    Diniz MS; Magalhães CC; Tocantins C; Grilo LF; Teixeira J; Pereira SP
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.
    Leiva A; Pardo F; Ramírez MA; Farías M; Casanello P; Sobrevia L
    Exp Diabetes Res; 2011; 2011():349286. PubMed ID: 22144986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetoplacental endothelial dysfunction in gestational diabetes mellitus and maternal obesity: A potential threat for programming cardiovascular disease.
    Diniz MS; Hiden U; Falcão-Pires I; Oliveira PJ; Sobrevia L; Pereira SP
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166834. PubMed ID: 37541330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High total cholesterol and triglycerides levels increase arginases metabolism, impairing nitric oxide signaling and worsening fetoplacental endothelial dysfunction in gestational diabetes mellitus pregnancies.
    Contreras-Duarte S; Cantin C; Farias M; Leiva A
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166216. PubMed ID: 34314821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium.
    San Martín R; Sobrevia L
    Placenta; 2006 Jan; 27(1):1-10. PubMed ID: 16310032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insulin, adenosine, and adipokine receptors in the foetoplacental vascular dysfunction in gestational diabetes mellitus.
    Subiabre M; Villalobos-Labra R; Silva L; Fuentes G; Toledo F; Sobrevia L
    Biochim Biophys Acta Mol Basis Dis; 2020 Feb; 1866(2):165370. PubMed ID: 30660686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human fetoplacental arterial and venous endothelial cells are differentially programmed by gestational diabetes mellitus, resulting in cell-specific barrier function changes.
    Cvitic S; Novakovic B; Gordon L; Ulz CM; Mühlberger M; Diaz-Perez FI; Joo JE; Svendova V; Schimek MG; Trajanoski S; Saffery R; Desoye G; Hiden U
    Diabetologia; 2018 Nov; 61(11):2398-2411. PubMed ID: 30091044
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.